IHAM

Integral Health Asset Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 40.53%
This Quarter Est. Return
1 Year Est. Return
+40.53%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$903M
AUM Growth
-$228M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
109
New
Increased
Reduced
Closed

Top Buys

1
+$28.3M
2
+$27.9M
3
+$22.6M
4
BAX icon
Baxter International
BAX
+$17.1M
5
ASND icon
Ascendis Pharma
ASND
+$15.6M

Top Sells

1
+$30.3M
2
+$29.6M
3
+$29.3M
4
ISRG icon
Intuitive Surgical
ISRG
+$20.9M
5
CVS icon
CVS Health
CVS
+$20.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATE icon
76
Fate Therapeutics
FATE
$190M
$553K 0.06%
700,000
+100,000
ACLX icon
77
Arcellx
ACLX
$4.7B
– –
-100,000
APLS icon
78
Apellis Pharmaceuticals
APLS
$3.56B
– –
-420,000
AZN icon
79
AstraZeneca
AZN
$258B
– –
-225,000
BRKR icon
80
Bruker
BRKR
$5.92B
– –
-100,000
CAH icon
81
Cardinal Health
CAH
$38.5B
– –
-250,000
CMPS
82
Compass Pathways
CMPS
$603M
– –
-200,000
CNC icon
83
Centene
CNC
$16.7B
– –
-500,000
COO icon
84
Cooper Companies
COO
$14.6B
– –
-100,000
DGX icon
85
Quest Diagnostics
DGX
$20.3B
– –
-130,000
EXAS icon
86
Exact Sciences
EXAS
$12.2B
– –
-150,000
PLRX icon
87
Pliant Therapeutics
PLRX
$111M
– –
-300,000
PODD icon
88
Insulet
PODD
$22.6B
– –
-20,000
QDEL icon
89
QuidelOrtho
QDEL
$2.07B
– –
-150,000
RNA icon
90
Avidity Biosciences
RNA
$7.17B
– –
0
RYTM icon
91
Rhythm Pharmaceuticals
RYTM
$7.34B
– –
-150,000
SLN
92
Silence Therapeutics
SLN
$345M
– –
-200,000
STAA icon
93
STAAR Surgical
STAA
$1.3B
– –
-100,000
SWTX
94
DELISTED
SpringWorks Therapeutics
SWTX
– –
-100,000
TGTX icon
95
TG Therapeutics
TGTX
$5.29B
– –
-150,000
TVTX icon
96
Travere Therapeutics
TVTX
$2.5B
– –
-100,000
VKTX icon
97
Viking Therapeutics
VKTX
$3.89B
– –
-150,000
WBA
98
DELISTED
Walgreens Boots Alliance
WBA
– –
-500,000
XENE icon
99
Xenon Pharmaceuticals
XENE
$3.14B
– –
0
ZNTL icon
100
Zentalis Pharmaceuticals
ZNTL
$123M
– –
-1,050,000
1 2 3
4
5